Skip to main content

Table 3 Appendix deviation from initial treatment pathway in Oesophagogastric cancer patients

From: Reflecting on the impact of the COVID pandemic on patient management and its subsequent influence on long-term outcomes: a case–control study in the field of esophago-gastric cancer

 

PP (2019)

P1 (2020)

P2 (2021)

Total

Did surgery happen? (p-value = 0.3864)

 Surgical intervention

54 (13.5%)

33 (12.7%)

59 (16.3%)

146 (14.3%)

 No Surgical intervention

346 (86.5%)

226 (87.3%)

303 (83.7%)

875 (85.7%)

Operations performed (p-value = 0.1729)

 Oesophagectomy

37 (68.5%)

19 (57.6%)

36 (61%)

92 (63%)

 Gastrectomy

16 (29.6%)

12 (36.4%)

22 (37.3%)

50 (34.2%)

 Palliative

1 (1.9%)

2 (6.1%)

1 (1.7%)

4 (2.7%)

Change intention from curative to palliative (p-value = 0.01381)

 Yes

9 (2.2%)

9 (3.5%)

23 (6.4%)

41 (4%)

 No

391 (97.8%)

250 (96.5%)

339 (93.6%)

980 (96%)

Change in modality with the same intent (p-value = 0.05055)

 Yes

15 (3.7%)

2 (0.8%%)

8 (2.2%)

25 (2.4%)

 No

385 (96.3%)

257 (99.2%)

354 (97.8%)

991 (97.1%)

Reasons for deviation from pathway (intention and/or modality) (p-value = 0.1464)

 Disease progression

10 (41.7%)

6 (54.5%)

22 (71%)

38 (57.6%)

 Incomplete resection

2 (8.3%)

2 (18.2%)

1 (3.2%)

5 (7.6%)

 Patient choice

1 (4.2%)

1 (9.1%)

2 (6.5%)

4 (6.1%)

 Patient deconditioned

11 (45.8%)

2 (18.2%)

6 (19.4%)

19 (28.8%)

 Total

24 (36.4%)

11 (16.7%)

31 (47%)

66